Global Cushing's Syndrome Treatment Market Size, Status and Forecast 2019-2025

Published On: Jun 2019

Format: PDF

Publisher: QY Research

Pages: 92

Report ID: 1335

Cushing's syndrome involves symptoms such as high blood pressure, abdominal obesity, round red face, a fatty lump between the shoulders, weak muscles and bones, acne, fragile skin and others. Most Cushing's syndrome cases are caused by pituitary adenoma, and multiple endocrine neoplasia.
In terms of value, North America is expected to be the dominant regional market for Cushing’s Syndrome treatment by 2025 and is expected to expand at a CAGR of 9% over the forecast period.
In 2018, the global Cushing's Syndrome Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Cushing's Syndrome Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Cushing's Syndrome Treatment development in United States, Europe and China.

The key players covered in this study
Pfizer
Novartis
Bristol-Myers Squibb
Corcept Therapeutics
HRA Pharma
Ipsen Biopharmaceuticals
...

Market segment by Type, the product can be split into
Glucocorticoid Receptor Inhibitors
Somatostatin
Ketoconazole HRA
Others

Market segment by Application, split into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Cushing's Syndrome Treatment status, future forecast, growth opportunity, key market and key players.
To present the Cushing's Syndrome Treatment development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Cushing's Syndrome Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Cushing's Syndrome Treatment Market Size Growth Rate by Type (2014-2025)
1.4.2 Glucocorticoid Receptor Inhibitors
1.4.3 Somatostatin
1.4.4 Ketoconazole HRA
1.4.5 Others
1.5 Market by Application
1.5.1 Global Cushing's Syndrome Treatment Market Share by Application (2014-2025)
1.5.2 Hospital Pharmacies
1.5.3 Retail Pharmacies
1.5.4 Online Pharmacies
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Cushing's Syndrome Treatment Market Size
2.2 Cushing's Syndrome Treatment Growth Trends by Regions
2.2.1 Cushing's Syndrome Treatment Market Size by Regions (2014-2025)
2.2.2 Cushing's Syndrome Treatment Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Cushing's Syndrome Treatment Market Size by Manufacturers
3.1.1 Global Cushing's Syndrome Treatment Revenue by Manufacturers (2014-2019)
3.1.2 Global Cushing's Syndrome Treatment Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Cushing's Syndrome Treatment Market Concentration Ratio (CR5 and HHI)
3.2 Cushing's Syndrome Treatment Key Players Head office and Area Served
3.3 Key Players Cushing's Syndrome Treatment Product/Solution/Service
3.4 Date of Enter into Cushing's Syndrome Treatment Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Cushing's Syndrome Treatment Market Size by Type (2014-2019)
4.2 Global Cushing's Syndrome Treatment Market Size by Application (2014-2019)

5 United States
5.1 United States Cushing's Syndrome Treatment Market Size (2014-2019)
5.2 Cushing's Syndrome Treatment Key Players in United States
5.3 United States Cushing's Syndrome Treatment Market Size by Type
5.4 United States Cushing's Syndrome Treatment Market Size by Application

6 Europe
6.1 Europe Cushing's Syndrome Treatment Market Size (2014-2019)
6.2 Cushing's Syndrome Treatment Key Players in Europe
6.3 Europe Cushing's Syndrome Treatment Market Size by Type
6.4 Europe Cushing's Syndrome Treatment Market Size by Application

7 China
7.1 China Cushing's Syndrome Treatment Market Size (2014-2019)
7.2 Cushing's Syndrome Treatment Key Players in China
7.3 China Cushing's Syndrome Treatment Market Size by Type
7.4 China Cushing's Syndrome Treatment Market Size by Application

8 Japan
8.1 Japan Cushing's Syndrome Treatment Market Size (2014-2019)
8.2 Cushing's Syndrome Treatment Key Players in Japan
8.3 Japan Cushing's Syndrome Treatment Market Size by Type
8.4 Japan Cushing's Syndrome Treatment Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Cushing's Syndrome Treatment Market Size (2014-2019)
9.2 Cushing's Syndrome Treatment Key Players in Southeast Asia
9.3 Southeast Asia Cushing's Syndrome Treatment Market Size by Type
9.4 Southeast Asia Cushing's Syndrome Treatment Market Size by Application

10 India
10.1 India Cushing's Syndrome Treatment Market Size (2014-2019)
10.2 Cushing's Syndrome Treatment Key Players in India
10.3 India Cushing's Syndrome Treatment Market Size by Type
10.4 India Cushing's Syndrome Treatment Market Size by Application

11 Central & South America
11.1 Central & South America Cushing's Syndrome Treatment Market Size (2014-2019)
11.2 Cushing's Syndrome Treatment Key Players in Central & South America
11.3 Central & South America Cushing's Syndrome Treatment Market Size by Type
11.4 Central & South America Cushing's Syndrome Treatment Market Size by Application

12 International Players Profiles
12.1 Pfizer
12.1.1 Pfizer Company Details
12.1.2 Company Description and Business Overview
12.1.3 Cushing's Syndrome Treatment Introduction
12.1.4 Pfizer Revenue in Cushing's Syndrome Treatment Business (2014-2019)
12.1.5 Pfizer Recent Development
12.2 Novartis
12.2.1 Novartis Company Details
12.2.2 Company Description and Business Overview
12.2.3 Cushing's Syndrome Treatment Introduction
12.2.4 Novartis Revenue in Cushing's Syndrome Treatment Business (2014-2019)
12.2.5 Novartis Recent Development
12.3 Bristol-Myers Squibb
12.3.1 Bristol-Myers Squibb Company Details
12.3.2 Company Description and Business Overview
12.3.3 Cushing's Syndrome Treatment Introduction
12.3.4 Bristol-Myers Squibb Revenue in Cushing's Syndrome Treatment Business (2014-2019)
12.3.5 Bristol-Myers Squibb Recent Development
12.4 Corcept Therapeutics
12.4.1 Corcept Therapeutics Company Details
12.4.2 Company Description and Business Overview
12.4.3 Cushing's Syndrome Treatment Introduction
12.4.4 Corcept Therapeutics Revenue in Cushing's Syndrome Treatment Business (2014-2019)
12.4.5 Corcept Therapeutics Recent Development
12.5 HRA Pharma
12.5.1 HRA Pharma Company Details
12.5.2 Company Description and Business Overview
12.5.3 Cushing's Syndrome Treatment Introduction
12.5.4 HRA Pharma Revenue in Cushing's Syndrome Treatment Business (2014-2019)
12.5.5 HRA Pharma Recent Development
12.6 Ipsen Biopharmaceuticals
12.6.1 Ipsen Biopharmaceuticals Company Details
12.6.2 Company Description and Business Overview
12.6.3 Cushing's Syndrome Treatment Introduction
12.6.4 Ipsen Biopharmaceuticals Revenue in Cushing's Syndrome Treatment Business (2014-2019)
12.6.5 Ipsen Biopharmaceuticals Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details